- Home
- OPFI vs SOPH Comparison
OPFI vs SOPH Comparison
Compare OPFI & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- SOPH
- Stock Information
- Founded
- OPFI 2009
- SOPH 2011
- Country
- OPFI United States
- SOPH Switzerland
- Employees
- OPFI N/A
- SOPH N/A
- Industry
- OPFI Finance: Consumer Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPFI Finance
- SOPH Health Care
- Exchange
- OPFI Nasdaq
- SOPH Nasdaq
- Market Cap
- OPFI 205.2M
- SOPH 206.6M
- IPO Year
- OPFI N/A
- SOPH 2021
- Fundamental
- Price
- OPFI $8.14
- SOPH $2.78
- Analyst Decision
- OPFI Buy
- SOPH Strong Buy
- Analyst Count
- OPFI 2
- SOPH 2
- Target Price
- OPFI $7.50
- SOPH $6.50
- AVG Volume (30 Days)
- OPFI 1.0M
- SOPH 36.0K
- Earning Date
- OPFI 05-07-2025
- SOPH 05-06-2025
- Dividend Yield
- OPFI 3.14%
- SOPH N/A
- EPS Growth
- OPFI N/A
- SOPH N/A
- EPS
- OPFI 0.36
- SOPH N/A
- Revenue
- OPFI $276,770,000.00
- SOPH $65,173,000.00
- Revenue This Year
- OPFI $112.50
- SOPH $14.83
- Revenue Next Year
- OPFI $7.84
- SOPH $22.79
- P/E Ratio
- OPFI $22.13
- SOPH N/A
- Revenue Growth
- OPFI 22.23
- SOPH 4.49
- 52 Week Low
- OPFI $2.56
- SOPH $2.60
- 52 Week High
- OPFI $17.73
- SOPH $6.28
- Technical
- Relative Strength Index (RSI)
- OPFI 39.26
- SOPH 41.46
- Support Level
- OPFI $7.81
- SOPH $2.70
- Resistance Level
- OPFI $8.49
- SOPH $3.00
- Average True Range (ATR)
- OPFI 0.60
- SOPH 0.29
- MACD
- OPFI 0.00
- SOPH -0.00
- Stochastic Oscillator
- OPFI 23.28
- SOPH 20.22
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.